Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study

Diab Vasc Dis Res. 2024 May-Jun;21(3):14791641241253967. doi: 10.1177/14791641241253967.
No abstract available

Publication types

  • Observational Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers* / blood
  • Blood Glucose Self-Monitoring*
  • Blood Glucose* / drug effects
  • Blood Glucose* / metabolism
  • Canada / epidemiology
  • Diabetes Mellitus, Type 2* / blood
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Glycated Hemoglobin* / metabolism
  • Glycemic Control* / adverse effects
  • Humans
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use
  • Male
  • Middle Aged
  • Predictive Value of Tests*
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Glycated Hemoglobin
  • Blood Glucose
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human
  • Biomarkers